Aditxt, Inc. (ADTX)
OTCMKTS · Delayed Price · Currency is USD
0.0021
-0.0002 (-8.70%)
At close: Jun 26, 2026
Aditxt Revenue
Aditxt had revenue of $12.16K in the quarter ending March 31, 2026, with 1,094.40% growth. This brings the company's revenue in the last twelve months to $14.34K, down -74.09% year-over-year. In the year 2025, Aditxt had annual revenue of $3.20K, down -97.62%.
Revenue (ttm)
14.34K
Revenue Growth
-74.09%
P/S Ratio
0.12
Revenue / Employee
551.38
Employees
26
Market Cap
1.71K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.20K | -130.79K | -97.62% |
| Dec 31, 2024 | 133.99K | -511.19K | -79.23% |
| Dec 31, 2023 | 645.18K | -288.54K | -30.90% |
| Dec 31, 2022 | 933.72K | 828.68K | 788.96% |
| Dec 31, 2021 | 105.03K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EV Biologics | 9.47M |
| Affimed | 6.29M |
| Alzex Neuropharma | 4.73M |
| DNAPrint Genomics | 1.93M |
| Trevena | 546.00K |
| Syros Pharmaceuticals | 386.00K |
Aditxt News
- 10 days ago - Why Is Penny Stock Aditxt (ADTX) Up Today? - TipRanks
- 19 days ago - Aditxt signs agreement valuing Ignite Proteomics at $150M - TheFly
- 19 days ago - Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Million - Business Wire
- 20 days ago - Ignite Proteomics Announces Prospective 10,000-Patient Oncology Registry to Evaluate Functional Proteomics in Cancer Therapy Selection - Business Wire
- 27 days ago - Aditxt appoints Busch as interim CEO - TheFly
- 27 days ago - Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders - Business Wire
- 6 weeks ago - Aditxt announces 1-for-27 reverse stock split - TheFly
- 6 weeks ago - Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026 - Business Wire